CN Stock MarketDetailed Quotes

300972 Fujian Wanchen Biotechnology Group

Watchlist

164.75
+17.75+12.07%

Market Closed Apr 30 15:00 CST

29.65BMarket Cap59.05P/E (TTM)

Fujian Wanchen Biotechnology Group Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fujian Wanchen Biotechnology Group Q1 2025 Earnings Date

Currency：CNYApr 29, 2025

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	--	10.82B	--
		+124.02%
EPS	--	1.07	--
		+2858.84%

Analyst Rating

Strong Buy

Apr 30, 2025

Fujian Wanchen Biotechnology Group Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2026/FY	-- / 63.601B	--
--	2025/FY	-- / 58.240B	--
--	2024/FY	32.329B / 31.857B	--
--	2023/FY	9.294B / 9.528B	--

DatePeriodRevenue/EstimateEarnings Call

--2026/FY-- / 63.601B--

--2025/FY-- / 58.240B--

--2024/FY32.329B / 31.857B--

--2023/FY9.294B / 9.528B--

--------

Unlock Free Earnings Estimates

Open Account

Fujian Wanchen Biotechnology Group Earnings Reports

Wan Chen Group: Report for the first quarter of 2025

Apr 28 12:00 ET

Wanchen Group: 2024 Annual Report Summary

Apr 18 12:00 ET

Wanchen Group: 2024 Annual Report

Apr 18 12:00 ET

Wanchen Group: Fujian Wanchen Biotechnology Group Co., Ltd. 2024 Annual Performance Forecast

Jan 24 03:44 ET